pharmaphorum

OCTOBER 20, 2021

A software platform developed by Altoida that uses augmented reality and artificial intelligence to diagnose neurological diseases in their earliest stages is being tested in a five-year trial involving thousands of patients.

Trials 78

Trials Genome Genomics Bioinformatics 78

XTalks

NOVEMBER 7, 2022

Gleich, MD, FACS, Senior Vice President, Medical Department, and Dr. Christopher Huth, PhD, Senior Clinical Trial Manager, Clinical Trial Management. Liquid Biopsy Use in Oncology Clinical Trials. How personalized, targeted assays can be developed to detect somatic mutations from cfDNA. “A percent show less reliability).

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

pharmaphorum

APRIL 15, 2021

When it comes to developing cutting-edge innovations, Astellas aims to be at the forefront. In the very early phase of development, Astellas also participates in public-private partnerships with academia, regulators, experts and beyond. The impact of COVID-19 and implications for the future.

Development 63

Development Manufacturing Production Bioinformatics 63

Drug Discovery World

JULY 11, 2023

Drug discovery and development timelines can span 10-15 years or more from initial discovery to market approval and typically require the analysis of massive amounts of data. How AI and ML are influencing drug development Biopharma has experienced significant growth in using these technologies for the past 10 years.

Big Data 40

Big Data Development Life Science Drugs 40

Drug Discovery World

MAY 1, 2024

This is reflected in collaboration and investment patterns; in 2023, Antiverse, a biotechnology company developing a computational antibody drug discovery platform, raised seed funding totalling £1.4 These enable researchers to better manipulate biological molecules or identify the best candidates to progress to the next stage of development.

Antibody 59

Antibody FDA Approval Drugs Development 59

Drug Discovery World

DECEMBER 7, 2023

New guidance for the motor neuron disease (MND) drug discovery community has been published to ensure that future drug discovery and development efforts have the best chance of successfully translating from the lab to the clinic.

Drugs 52

Drugs Bioinformatics Clinical Trials Clinical Trials 52

Drug Discovery World

OCTOBER 20, 2023

The latest acquisitions and strategic partnerships in the drug discovery and development sector reveal the areas where companies predict significant growth in the near future: proteomics, CAR-T, antibody discovery, artificial intelligence (AI) and microbiomics. Olink specialises in solutions for proteomics discovery and development.

Drugs 52

Drugs Antibody DNA Gene Therapy 52

pharmaphorum

APRIL 1, 2021

We speak to the company’s CEO and co-founder, Szabolcs Nagy, to find out why moving beyond traditional biotech drug development is a good fit for the country’s ecosystem. They go into bioinformatics”. It’s incredibly exciting to see what can be done with the right data and digital expertise combined with experienced drug developers.

Bioinformatics 106

Bioinformatics Drugs Development Scientist 106

Drug Discovery World

JULY 27, 2023

In a DDW Sitting Down With podcast with Lu Rahman, Ruth Roberts and Claire Sadler , ApconiX, discuss the benefits of performing a target safety assessment (TSA) during drug discovery and development when a biological target is going to be acted on by a drug. Over 40% of drug safety failures are due to the drug target.

Bioinformatics 52

Bioinformatics Drugs In-Vitro Development 52

Drug Discovery World

NOVEMBER 7, 2022

They subsequently applied additional bioinformatic approaches, using advanced computer technologies to identify genetic alterations in a patients’ DNA which may be causing disease but had been overlooked during routine testing. . It can also permit targeted screening of known disease complications and access to drug studies.

Genome 52

Genome Genomics Genetics Genetic Disease 52

Drug Discovery World

APRIL 6, 2023

The workshop will be led by hfp consulting, a firm which specialises in career development and leadership training for scientists. These topics will be represented across a range of session types, including methods workshops, minisymposia, poster and plenary sessions, as well as keynotes, awards and lectures.

Protein 52

Protein Clinical Trials Clinical Trials Antibody 52

STAT News

MARCH 6, 2023

Cambridge-based Moderna recently reported encouraging results from a study of another type of personalized cancer vaccine it developed with the pharmaceutical giant Merck; it uses messenger RNA technology to target advanced melanoma. Therapeutic vaccines represent the next frontier in cancer medicine.

Vaccination 98

Vaccination Vaccine Drugs Clinical Trials 98

Drug Discovery World

APRIL 18, 2023

would not have qualified for genetic screening under current guidelines, according to results from the Tapestry clinical trial presented at AACR 2023 today. Among individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for hereditary breast and ovarian cancer (HBOC) or Lynch syndrome, 39.2%

Genetics 52

Genetics DNA Research Bioinformatics 52

Scienmag

JUNE 22, 2021

Credit: Insilco June 22, 2021, New York / Hong Kong — Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million from biotechnology experts to progress Insilico Medicine’s current therapeutic programs into (..)

Medicine 55

Medicine Clinical Trials Clinical Trials Clinical Development 55

XTalks

SEPTEMBER 28, 2020

The test was developed by Resolution Bioscience and the company will run test analyses in its labs. Related: Liquid Biopsies Help Match Cancer Patients to Phase I Trials. The Resolution ctDx Lung assay was developed to offer patients and clinicians with pertinent information that can inform treatment decisions.

Gene 105

Gene DNA Life Science Genotype 105

Drug Discovery World

OCTOBER 7, 2022

Developing immunotherapies for high-risk breast cancer patients. This new insight into the behaviour of NK cells could be used to develop specific immunotherapies for these high-risk patients. This would need to be investigated in future clinical trials. NK cells help the body to fight infection and cancer.

Research 52

Research Immune Response Gene Bioinformatics 52

XTalks

MAY 20, 2022

A clinical scientist conducts research to help prevent illness and develops techniques to support patient diagnosis and treatment. They also assist in the testing of medical devices and development of drug products. To start applying to clinical scientist jobs today, head over to the Xtalks Job Search platform.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

The Pharma Data

JULY 27, 2021

Amgen (NASDAQ: AMGN) and Teneobio today announced an agreement under which Amgen will acquire Teneobio, a privately held, clinical stage biotechnology company developing a new class of biologics called Human Heavy-Chain Antibodies. executive vice president of Research and Development at Amgen. billion in cash. Reese, M.D.,

Production 52

Production Antibody Sales Manufacturing 52

XTalks

SEPTEMBER 5, 2023

Vaccines have been an integral piece of the global public health toolbox for over 200 years, but the COVID-19 pandemic brought about a new era in vaccine development with renewed interest in mRNA technology and unprecedented accelerated regulatory approvals. What are the major challenges you’re facing right now in vaccine development?

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

Drug Discovery World

APRIL 14, 2023

He is being recognised for his revolutionary contributions to developing the first gene-edited cell-based therapy for cancer that involves the genetic re-engineering of a patient’s own T cells to combat their disease, and for demonstrating that adoptive T-cell therapy can induce remission and in some cases cure patients with advanced cancer.

Genetics 52

Genetics Research Medicine Clinical Research 52

The Pharma Data

SEPTEMBER 1, 2020

.–( BUSINESS WIRE )– Bristol Myers Squibb (NYSE:BMY) today announced interim results from the Phase 3 open-label extension trial DAYBREAK, demonstrating the long-term efficacy and safety profile of Zeposia (ozanimod) in patients with relapsing forms of multiple sclerosis (MS). of participants in the trial, respectively.

Trials 52

Trials Clinical Trials Clinical Trials Vaccination 52

Scienmag

JUNE 22, 2021

Minseok Kim of the Department of New Biology, DGIST, was selected for the ‘200 Baby Unicorns Fostering Project’ organized by Ministry of SMEs and Startups(MSS) and Korea Institute of Startup & Entrepreneurship Development(KISED), recently. MSS recently […].

Development 55

Development Clinical Trials Clinical Trials Bioinformatics 55

Drug Discovery World

JULY 26, 2023

An industry overview of the role of the microbiome in precision medicine, and its interplay with research tools, diagnostics, and therapeutic development. These novel tools are facilitating the exploration of the microbiome in diagnostics development and drug discovery.

Medicine 52

Medicine Genome Genomics Bioinformatics 52

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. It also helps to quickly address unplanned changes.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

XTalks

APRIL 21, 2023

WGS remains at the core of developing personalized medicine against cancer as it provides valuable information for cancer etiology and progression. Biotech company Ultima Genomics has joined forces with Genome Insight, a bioinformatics-based biomedicine company, to overcome the caveat of cost and quality in WGS.

Genome 97

Genome Genomics Bioinformatics Genetics 97

Drug Discovery World

OCTOBER 25, 2023

DDW Editor Reece Armstrong speaks to Dr Darrell Green , Lecturer in RNA Biology Biomedical Research Centre Norwich Medical School University of East Anglia, about his work using next generation sequencing (NGS) and the areas the technology is impacting within drug discovery and development.

Bioinformatics 115

Bioinformatics Genetics RNA Drugs 115

The Pharma Data

DECEMBER 8, 2020

.” Orphan drug designation is granted by the FDA Office of Orphan Products Development (OOPD) to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases or conditions affecting fewer than 200,000 people in the U.S.

Drugs 40

Drugs FDA Approval Marketing Containment 40

XTalks

DECEMBER 13, 2023

In 2023, biotechnology and pharmaceutical companies leverage cutting-edge technology and significant investments in research and development (R&D) to continue pushing the boundaries of innovation in the healthcare sector, transcending the challenges posed by the pandemic.

Genetics 111

Genetics Vaccination Vaccine DNA 111

pharmaphorum

APRIL 8, 2021

million that will be used to take its personalised T cell therapy for lung and skin cancers through proof-of-concept trials. London-based Achilles has a bioinformatics platform called PELEUS that can identify clonal neoantigens in a patient, and an automated production platform – known as VELOS – to make the therapy.

Research 60

Research Bioinformatics Life Science Manufacturing 60

Drug Discovery World

JULY 19, 2023

The tide has been turning in the worlds of diagnostics and drug development. Bioinformatics and genetic sequencing are starting to be placed front and centre of public research programmes as scientists from around the world recognise the substantial benefits of knowledge sharing and resource pooling when it comes to genetic science.

Genome 52

Genome Genomics Bioinformatics Genetics 52

pharmaphorum

SEPTEMBER 14, 2020

Through his work at the Wellcome Sanger Institute and Congenica, and involvement with the 100,000 Genomes Project, Charlie has been well placed to see the development of genomics over the years and the promises that it will bring to healthcare. Luckily there have been some encouraging developments in sequencing technology in recent years.

Genome 118

Genome Genomics Medicine Gene 118

The Pharma Data

OCTOBER 27, 2020

The growth in Orenitram revenues resulted primarily from an increase in quantities sold, as the number of patients being treated with Orenitram grew following the update to Orenitram’s labeling to reflect the FREEDOM-EV clinical trial results, partially offset by the impact of the Excess Order. Expenses. . .

Production 40

Production Sales Licensing Licensing 40

Drug Discovery World

NOVEMBER 30, 2023

Lightcast is developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. “It GSK has developed high-throughput mammalian and E.

Antibody 59

Antibody Protein Engineer In-Vivo 59

pharmaphorum

MARCH 28, 2022

Via its third call for applications, AION and BioMed X aims to entice innovative thinkers to find ways to develop solutions to common pharma challenges by analysing existing antibody therapies to make new efficient and effective therapies using AI. Then, a development stage or optimisation stage occurs.

Pharma Companies 98

Pharma Companies Antibody Protein Development 98

The Pharma Data

JANUARY 10, 2021

His company is leveraging the novel cellular immunotherapy development platform he invented to develop novel, targeted, allogeneic cell therapies against cancer with NK cells, the body’s immune cells that specialize in recognizing and attacking cancer cells. Can we develop…almost a preventative therapeutic approach?

Vaccination 52

Vaccination Vaccine Regulation Drugs 52